Abstract
In this article the clinical experiences with the new nonsulphydryl angiotensin-converting enzyme inhibitor trandolapril are reviewed. The drug lowers blood pressure effectively in patients with mild-to-severe hypertension including elderly and obese patients. Distinguishing features of the compound are its long plasma half-life and high degree of lipophilicity. © 1993.
| Original language | English |
|---|---|
| Pages (from-to) | 1542-1546 |
| Number of pages | 5 |
| Journal | American Heart Journal |
| Volume | 125 |
| Issue number | 5 PART 2 |
| DOIs | |
| Publication status | Published - 1993 |
| Externally published | Yes |
Keywords
- Angiotensin-Converting Enzyme Inhibitors/*therapeutic use Clinical Trials as Topic Humans Hypertension/*drug therapy Indoles/*therapeutic use
Fingerprint
Dive into the research topics of 'Clinical experiences with trandolapril'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver